A detailed history of Steward Financial Group LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Steward Financial Group LLC holds 130 shares of CTLT stock, worth $7,755. This represents 0.0% of its overall portfolio holdings.

Number of Shares
130
Holding current value
$7,755
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

BUY
$44.2 - $50.2 $5,746 - $6,526
130 New
130 $5,000
Q2 2022

Jul 22, 2022

BUY
$87.2 - $114.05 $3,749 - $4,904
43 New
43 $4,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.7B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Steward Financial Group LLC Portfolio

Follow Steward Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Financial Group LLC with notifications on news.